The New Brunswick Pharmacy Assessment Clinic: A Novel, Pharmacist-Led, Virtual Collaborative Practice Hub for the Assessment and Prescribing of Nirmatrelvir/Ritonavir for Patients with COVID-19

Overview

Journal Can J Hosp Pharm

Date 2023 Sep 28

PMID 37767393

Authors

Bradley B Adams

Britney Sansom

Nadine Doiron

Douglas Doucette

Josee Gagnon

Daniel Landry

Michael LeBlanc

Julie Levesque

Faith Louis

Timothy MacLaggan

Heather K Naylor

Affiliations

Soon will be listed here.

Citing Articles

Health Care Workers' Perceptions of a Pharmacist-Led Collaborative Practice Agreement for Prescribing Nirmatrelvir/Ritonavir to Eligible Patients with COVID-19.

Sansom B, Adams B, Canales D, Doucette D, Gagnon J, LeBlanc M Can J Hosp Pharm. 2025; 78(1):e3596.

PMID: 39944758 PMC: 11801458. DOI: 10.4212/cjhp.3596.

References

Bungard T, Schindel T, Brocklebank C . A description of a multistaged professional development course for practising pharmacists in anticoagulation management. Can Pharm J (Ott). 2013; 145(1):14-16.e1. PMC: 3567540. DOI: 10.3821/1913-701X-145.1.14. View

Gebru A, Birhanu T, Wendimu E, Ayalew A, Mulat S, Abasimel H . Global burden of COVID-19: Situational analyis and review. Hum Antibodies. 2020; 29(2):139-148. DOI: 10.3233/HAB-200420. View

Zillich A, McDonough R, Carter B, Doucette W . Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004; 38(5):764-70. DOI: 10.1345/aph.1D419. View

Bryk A, Koontz S, Mayor J, Betcher J, Tombleson R, Bookout R . Characterization of collaborative practice agreements held by hematopoietic stem cell transplant pharmacists. J Oncol Pharm Pract. 2017; 25(3):558-566. DOI: 10.1177/1078155217745145. View

Lott B, Anderson E, Villa Zapata L, Cooley J, Forbes S, Taylor A . Expanding pharmacists' roles: Pharmacists' perspectives on barriers and facilitators to collaborative practice. J Am Pharm Assoc (2003). 2020; 61(2):213-220.e1. DOI: 10.1016/j.japh.2020.11.024. View

Brock K, Doucette W . Collaborative working relationships between pharmacists and physicians: an exploratory study. J Am Pharm Assoc (2003). 2004; 44(3):358-65. DOI: 10.1331/154434504323063995. View

De Moissac D, Bowen S . Impact of Language Barriers on Quality of Care and Patient Safety for Official Language Minority Francophones in Canada. J Patient Exp. 2019; 6(1):24-32. PMC: 6572938. DOI: 10.1177/2374373518769008. View

Jalili M, Niroomand M, Hadavand F, Zeinali K, Fotouhi A . Burnout among healthcare professionals during COVID-19 pandemic: a cross-sectional study. Int Arch Occup Environ Health. 2021; 94(6):1345-1352. PMC: 8052946. DOI: 10.1007/s00420-021-01695-x. View

Kelly D, Bishop L, Young S, Hawboldt J, Phillips L, Keough T . Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott). 2013; 146(4):218-26. PMC: 3734911. DOI: 10.1177/1715163513492642. View

10.

Yuksel N, Eberhart G, Bungard T . Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008; 65(22):2126-32. DOI: 10.2146/ajhp080247. View

11.

Pearson G . Remote Pharmacist Practice Model of Collaboration in Primary Care: Potential for Benefit or an Opportunity Lost?. Circ Cardiovasc Qual Outcomes. 2018; 11(6):e004801. DOI: 10.1161/CIRCOUTCOMES.118.004801. View

12.

Famularo D, Koloski J, Marathe J, Au A, Hamilton S, Mordino J . Pharmacist-driven assessment and prescribing of COVID-19 therapeutics: A large, tertiary academic medical center's experience. Am J Health Syst Pharm. 2022; 79(21):1889-1893. PMC: 9384582. DOI: 10.1093/ajhp/zxac213. View